The fitness wearable market is increasingly focused on personalized health insights, and Whoop is the latest company to deepen its commitment to women’s health. On Tuesday, the company announced the launch of a latest blood test panel specifically designed to provide data-driven understanding of key biomarkers related to female physiology. This expansion comes alongside a new feature within the Whoop app aimed at predicting and interpreting hormonal fluctuations throughout the menstrual cycle, signaling a broader industry trend toward addressing the historically underserved needs of female users.
Whoop’s new offering, part of its Whoop Labs blood testing service, analyzes 11 distinct biomarkers. These include Anti-Müllerian Hormone (AMH), Progesterone, Prolactin, and Thyroid Peroxidase Antibodies (TPOAb), alongside Free T4, Free T3, Leptin, Vitamin B12 (Cobalamin), Folate, Magnesium, and Phosphate (as Phosphorus). According to Whoop, analyzing these markers, when combined with the company’s existing data on activity, sleep, and recovery, can offer valuable insights into areas like cycle regulation, hormonal transitions, thyroid function, nutrient sufficiency, and bone metabolic resilience. This holistic approach aims to move beyond simply reporting lab results and instead provide actionable, personalized guidance.
Addressing a Growing Demand for Women’s Health Tech
The launch of this new panel reflects a growing recognition within the wearable technology industry of the need to cater to the specific health needs of women. Earlier this month, Oura, a smart ring manufacturer, unveiled a new artificial intelligence model focused on women’s health, accompanied by a chatbot designed to provide personalized health insights. This move underscores a broader trend of companies seeking to fill gaps in health tracking that have historically overlooked female-specific physiological factors.
Whoop reported a significant 150% increase in female users over the past year, now representing its fastest-growing user segment. The company also noted that women demonstrate 30% higher engagement with its Whoop AI feature, suggesting a strong appetite for data-driven health insights tailored to their needs. This growth is further evidenced by the substantial waitlist for Whoop’s blood testing service, which exceeded 350,000 individuals when it launched in September 2025.
Hormonal Cycle Tracking and Personalized Insights
Complementing the new blood test panel, Whoop’s app is receiving an update that introduces Hormonal Symptom Insights and Predictions. This feature leverages data collected over time to create a personalized model of an individual’s hormonal fluctuations throughout their menstrual cycle. The app can then predict potential dates for upcoming periods, provide insights into cycle length and irregularities, and detail individual symptom patterns. Crucially, Whoop states it can integrate these insights with lab results, categorizing biomarker results as ‘optimal,’ ‘sufficient,’ or ‘out of range’ to provide a more nuanced and actionable interpretation.
To further support these new features, Whoop has released a white paper detailing the modeling behind its menstrual cycle insights. This transparency aims to build trust and provide users with a deeper understanding of the data driving the app’s predictions and recommendations. The white paper is available for download on the company’s website: WHOOP Menstrual Cycle Insights White Paper.
Looking Ahead
The new blood test panel and app features will be available for purchase next month. This launch positions Whoop as a key player in the burgeoning market for women’s health technology, alongside companies like Oura. In October 2025, Dorothy Kilroy, Oura’s chief commercial officer, told TechCrunch that their fastest-growing user base was women in their twenties, highlighting the significant potential within this demographic.
As the demand for personalized health data continues to grow, it’s likely we’ll see further innovation in this space. The focus on providing actionable insights, rather than simply raw data, will be crucial for empowering individuals to take control of their health and well-being. Whoop’s latest offerings represent a step in that direction, and the company’s continued investment in women’s health will be one to watch in the coming months.
The next major event to watch for is the availability of the new blood test panel next month. We will continue to follow developments in this space and provide updates as they turn into available. What are your thoughts on the increasing focus on women’s health within the wearable tech industry? Share your comments below, and let’s continue the conversation.